- Home
- LUCD vs OFS Comparison
LUCD vs OFS Comparison
Compare LUCD & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- OFS
- Stock Information
- Founded
- LUCD 2018
- OFS 2001
- Country
- LUCD United States
- OFS United States
- Employees
- LUCD N/A
- OFS N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OFS Finance/Investors Services
- Sector
- LUCD Health Care
- OFS Finance
- Exchange
- LUCD Nasdaq
- OFS Nasdaq
- Market Cap
- LUCD 108.0M
- OFS 117.0M
- IPO Year
- LUCD 2021
- OFS 2012
- Fundamental
- Price
- LUCD $1.04
- OFS $7.55
- Analyst Decision
- LUCD Strong Buy
- OFS
- Analyst Count
- LUCD 5
- OFS 0
- Target Price
- LUCD $3.70
- OFS N/A
- AVG Volume (30 Days)
- LUCD 1.5M
- OFS 70.9K
- Earning Date
- LUCD 11-12-2025
- OFS 10-30-2025
- Dividend Yield
- LUCD N/A
- OFS 17.62%
- EPS Growth
- LUCD N/A
- OFS N/A
- EPS
- LUCD N/A
- OFS 0.76
- Revenue
- LUCD $4,360,000.00
- OFS $43,337,000.00
- Revenue This Year
- LUCD $13.90
- OFS N/A
- Revenue Next Year
- LUCD $163.88
- OFS N/A
- P/E Ratio
- LUCD N/A
- OFS $10.10
- Revenue Growth
- LUCD 14.74
- OFS N/A
- 52 Week Low
- LUCD $0.75
- OFS $7.53
- 52 Week High
- LUCD $1.80
- OFS $9.80
- Technical
- Relative Strength Index (RSI)
- LUCD 43.56
- OFS 30.67
- Support Level
- LUCD $1.00
- OFS $7.53
- Resistance Level
- LUCD $1.06
- OFS $7.81
- Average True Range (ATR)
- LUCD 0.04
- OFS 0.22
- MACD
- LUCD -0.00
- OFS -0.07
- Stochastic Oscillator
- LUCD 28.57
- OFS 10.27
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.